Daiwa Securities Group Inc. - INTRA CELLULAR THERAPIES INC ownership

INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 265 filers reported holding INTRA CELLULAR THERAPIES INC in Q2 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.3%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of INTRA CELLULAR THERAPIES INC
ValueSharesWeighting
Q3 2023$18
-18.2%
3450.0%0.00%
Q2 2023$22
+4.8%
345
-9.4%
0.00%
Q1 2023$21
+5.0%
3810.0%0.00%
Q4 2022$20
-99.9%
381
+8.2%
0.00%
Q3 2022$16,000
-20.0%
3520.0%0.00%
Q2 2022$20,000
+17.6%
352
+27.1%
0.00%
Q1 2022$17,000
+41.7%
277
+16.4%
0.00%
Q4 2021$12,000
+20.0%
238
-14.7%
0.00%
Q3 2021$10,000
+66.7%
279
+84.8%
0.00%
Q2 2021$6,000
+20.0%
1510.0%0.00%
Q1 2021$5,0000.0%1510.0%0.00%
Q4 2020$5,000
-44.4%
151
-58.5%
0.00%
Q3 2020$9,000
+50.0%
3640.0%0.00%
Q2 2020$6,0000.0%3640.0%0.00%
Q1 2020$6,000
-40.0%
364
+20.5%
0.00%
Q4 2019$10,000
+400.0%
3020.0%0.00%
Q3 2019$2,000
-50.0%
3020.0%0.00%
Q2 2019$4,0000.0%3020.0%0.00%
Q1 2019$4,000
+33.3%
3020.0%0.00%
Q4 2018$3,000
-57.1%
3020.0%0.00%
Q3 2018$7,000
+40.0%
3020.0%0.00%
Q2 2018$5,000
-16.7%
3020.0%0.00%
Q1 2018$6,0003020.00%
Other shareholders
INTRA CELLULAR THERAPIES INC shareholders Q2 2022
NameSharesValueWeighting ↓
Sarissa Capital Management LP 640,000$25,626,0006.33%
Redmile Group, LLC 1,322,592$52,957,0004.01%
SENZAR ASSET MANAGEMENT, LLC 556,224$22,271,209,0003.24%
RA Capital Management 314,349$12,587,0001.81%
WALL STREET ASSOCIATES 205,657$8,235,0001.58%
Parametrica Management Ltd 5,400$216,0001.36%
Rhenman & Partners Asset Management AB 165,000$6,607,0001.05%
EAM Investors, LLC 95,168$3,811,0000.60%
Rock Springs Capital Management LP 180,000$7,207,0000.58%
WASATCH ADVISORS LP 1,085,973$43,482,0000.58%
View complete list of INTRA CELLULAR THERAPIES INC shareholders